• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺增生患者动脉高血压的发病率、病程特点及治疗]

[The incidence, features of the course, and treatment of arterial hypertension in patients with prostate hyperplasia].

作者信息

Ukhal' M I, Strashnyĭ V V, Ukhal' G M, Shumilin M V

出版信息

Lik Sprava. 2003(2):53-5.

PMID:12774476
Abstract

In 144 middle-aged and elderly male subjects with benign prostate hyperplasia, a study was made into incidence and course features of concomitant arterial hypertension (AH). AH has been proved to be encountered in 144 percent of patients with benign hyperplasia of the prostate. It has been ascertained that in 84% of patients, irritative and obstructive symptoms related to benign hyperplasia of the prostate adversely affect the course of concomitant arterial hypertension. Striking reduction of manifestations of benign prostate hyperplasia-related irritative and obstructive symptoms using cardura, a selective alpha-adrenoblocker, has come to significantly enhance efficiency of treatment of concurrent AH.

摘要

在144名患有良性前列腺增生的中老年男性受试者中,对伴发动脉高血压(AH)的发病率和病程特征进行了研究。已证实,在前列腺良性增生患者中有144%会出现AH。已确定,在84%的患者中,与前列腺良性增生相关的刺激性和梗阻性症状会对伴发的动脉高血压病程产生不利影响。使用选择性α-肾上腺素能阻滞剂可多华显著减轻与前列腺良性增生相关的刺激性和梗阻性症状,从而显著提高并发AH的治疗效果。

相似文献

1
[The incidence, features of the course, and treatment of arterial hypertension in patients with prostate hyperplasia].[前列腺增生患者动脉高血压的发病率、病程特点及治疗]
Lik Sprava. 2003(2):53-5.
2
[The effect of symptomatic therapy with the alpha 1-adrenoblocker Cardura in patients with benign prostatic hyperplasia on the course of cardiovascular diseases].[α1-肾上腺素能阻滞剂可多华对良性前列腺增生患者进行对症治疗对心血管疾病进程的影响]
Lik Sprava. 1999 Jul(5):128-31.
3
[Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
Urol Nefrol (Mosk). 1998 May-Jun(3):3-5.
4
[Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].[α1肾上腺素受体拮抗剂多沙唑嗪(可多华-辉瑞公司生产)在糖尿病患者高血压治疗中的应用]
Wiad Lek. 1998;51 Suppl 2:5-10.
5
A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).一项关于多沙唑嗪治疗伴发高血压和症状性良性前列腺增生的多中心、基于社区的研究:高血压与良性前列腺增生干预试验(HABIT)。
Clin Ther. 1999 Oct;21(10):1732-48. doi: 10.1016/s0149-2918(99)80052-6.
6
[Clinical and neuroimmunoendocrine effects of doxasosine in treatment of arterial hypertension accompanied by prostate benign hyperplasia in elderly people].
Klin Med (Mosk). 2008;86(5):39-41.
7
Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia.多沙唑嗪对血压正常和高血压的良性前列腺增生患者的疗效。
Scand J Urol Nephrol Suppl. 1995;168:29-33.
8
[Cardura (doxazosin) in the treatment of prostatic adenoma].可多华(多沙唑嗪)治疗前列腺腺瘤
Lik Sprava. 1997 Sep-Oct(5):135-7.
9
Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.多沙唑嗪治疗良性前列腺增生:一项在韩国普通医疗实践中的开放标签、基线对照研究。
Int J Urol. 2005 Feb;12(2):159-65. doi: 10.1111/j.1442-2042.2005.00998.x.
10
Profile of doxazosin in patients with benign prostatic hyperplasia.多沙唑嗪在良性前列腺增生患者中的概况。
Scand J Urol Nephrol Suppl. 1995;168:21-7.